Cargando…
A Blood-Based Screening Tool for Alzheimer's Disease That Spans Serum and Plasma: Findings from TARC and ADNI
CONTEXT: There is no rapid and cost effective tool that can be implemented as a front-line screening tool for Alzheimer's disease (AD) at the population level. OBJECTIVE: To generate and cross-validate a blood-based screener for AD that yields acceptable accuracy across both serum and plasma. D...
Autores principales: | O'Bryant, Sid E., Xiao, Guanghua, Barber, Robert, Huebinger, Ryan, Wilhelmsen, Kirk, Edwards, Melissa, Graff-Radford, Neill, Doody, Rachelle, Diaz-Arrastia, Ramon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3233542/ https://www.ncbi.nlm.nih.gov/pubmed/22163278 http://dx.doi.org/10.1371/journal.pone.0028092 |
Ejemplares similares
-
Serum Granulocyte Colony-Stimulating Factor and Alzheimer's Disease
por: Barber, Robert C., et al.
Publicado: (2012) -
Can Genetic Analysis of Putative Blood Alzheimer’s Disease Biomarkers Lead to Identification of Susceptibility Loci?
por: Barber, Robert C., et al.
Publicado: (2015) -
A blood screening test for Alzheimer's disease
por: O'Bryant, Sid E., et al.
Publicado: (2016) -
Molecular markers of neuropsychological functioning and Alzheimer's disease
por: Edwards, Melissa, et al.
Publicado: (2015) -
TOF and TARC
Publicado: (2000)